.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

AstraZeneca
Chubb
Baxter
US Department of Justice
Covington
Argus Health
UBS
Teva
Dow
Citi

Generated: September 26, 2017

DrugPatentWatch Database Preview

Drug Master Files for: Pliva

« Back to Dashboard

DMF No. Status Type Submission Date Holder Subject
2739III8/30/1976PLIVA HRVATSKA DOOSULFISOXAZOLE
2847III2/4/1977PLIVA PHARMACEUTICAL CHEMICAL FOOD & COSMETIC INDUSTRYMECLIZINE HCL
2885III3/17/1977PLIVA PHARMACEUTICAL CHEMICAL FOOD & COSMETIC INDUSTRYCHLORPROPAMIDE
4168III5/7/1981PLIVA PHARMACEUTICAL CHEMICAL FOOD & COSMETIC INDUSTRYGLUTETHIMIDE (CHEM NAME: 2-ETHYL-2-PHENYL GLUTARIMIDE)
4610III6/16/1982PLIVA PHARMACEUTICAL CHEMICAL FOOD & COSMETIC INDUSTRYCHLOROTHIAZIDE
8349III12/29/1989PLIVA PHARMACEUTICAL CHEMICAL FOOD & COSMETIC INDUSTRYCHLORHEXIDINE BASE
8363III12/18/1989PLIVA PHARMACEUTICAL CHEMICAL FOOD & COSMETIC INDUSTRYCHLORHEXIDINE GLUCONATE SOLUTION
8408III1/29/1990PLIVA CROATIA LTDFACILITY FOR AZITHROMICIN DIHYDRATE G. IN ZAGREB, YUGOSLAVIA
8551III4/23/1990PLIVA PHARMACEUTICAL CHEMICAL FOOD & COSMETIC INDUSTRYKETOPROFEN
9539III2/13/1992PLIVA CROATIA LTDMETOPROLOL TARTRATE
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.


Drug Master File Glossary

STATUS OF DMFS

  • A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
  • I = Inactive
  • N = Not an assigned number
  • P = DMF Pending Filing Review

TYPES OF DMFs

  • Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
  • Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
  • Type III Packaging Material
  • Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
  • Type V FDA Accepted Reference Information

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Medtronic
Citi
Cipla
Covington
Federal Trade Commission
Harvard Business School
Boehringer Ingelheim
Moodys
US Department of Justice
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot